Critical Biomarker Raw Material Manufacturer
Renduan Biomed is an innovation-driven biotechnology manufacturer specialized in the discovery, engineering, and bulk industrial supply of high-affinity antibodies, recombinant antigens, and authentic calibrators for clinical in vitro diagnostics (IVD).
Engineering Diagnostic Reliability at the Source
Headquartered in Suzhou’s biopharma innovation corridor, Suzhou Renduan Biomedical Technology Co., Ltd. (Renduan Biomed) was established in 2017. Certified as a National High-Tech Enterprise and Provincial Science & Technology Innovator, we operate at the critical foundation of the medical value chain—providing assay developers and IVD kit manufacturers worldwide with batch-consistent, high-affinity diagnostic raw materials.
Our R&D team brings deep translational expertise in hybridoma discovery, recombinant protein engineering, and clinical immunoassay verification. Specializing in high-barrier disease panels—particularly neurodegenerative diseases (Alzheimer’s, ALS, Parkinson’s), acute brain injury, cardiovascular pathology, and systemic inflammation—we bridge early-stage discovery with multi-gram industrial biomanufacturing.
Proprietary Technology Platforms
Our end-to-end technical capabilities span target sequence design through industrial-scale batch release:
Monoclonal Antibody Discovery
Proprietary hybridoma sequencing and single-cell screening platforms yielding ultra-high affinity clones optimized for sandwich immunoassays.
Recombinant Protein Engineering
High-fidelity mammalian (HEK293/CHO) and microbial expression systems for post-translationally modified targets, phosphorylation sites, and authentic calibrators.
Stable Cell Line Generation
Robust host engineering ensuring consistent expression titers, genetic stability, and zero lot-to-lot kinetic drift during multi-gram scale-up.
Clinical Immunoassay Validation
In-house pre-screening across magnetic microparticle CLIA, ELISA, and digital single-molecule (Simoa) platforms benchmarked against real clinical matrices.
Our brand name, Renduan (仁端), originates from the classical philosophy of human compassion as the foundation of benevolent action. In modern diagnostics, we translate this philosophy into an uncompromising commitment to early disease detection. By engineering ultrasensitive reagents for preclinical Alzheimer’s and chronic diseases, we empower clinicians and diagnostic developers to detect cellular pathology years before irreversible clinical onset—advancing healthier futures globally.
Industrial Quality Assurance & Standards
Quality is the cornerstone of clinical assay reproducibility. Renduan Biomed enforces stringent biophysical release criteria across every manufacturing run. Each batch is validated through orthogonal analytical batteries, including SDS-PAGE purity, analytical SEC-HPLC monomer verification (>98%), real-time kinetic determination (BLI/SPR), and spike-recovery testing in human serum and plasma.
- Intellectual Property & Governance: Multiple granted national invention patents, proprietary clone banks, and strict mutual NDA IP protection.
- Flexible OEM & Formulation: Preservative-free (sodium azide-free) formulations, custom buffer matrices, acridinium ester/biotin labeling, and sterile bulk fill options.
- Global Cold-Chain Logistics: Established temperature-controlled international shipping with comprehensive Certificates of Analysis (CoA) and regulatory tech dossiers included with every shipment.
Partner with an In-House Diagnostic Manufacturer
Whether you require small evaluation sample packs for assay feasibility or multi-gram industrial supply contracts, our scientific team is ready to support your development pipeline.